These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention. Mathur VS Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361 [TBL] [Abstract][Full Text] [Related]
3. Current trials of interventions to prevent radiocontrast-induced nephropathy. Asif A; Garces G; Preston RA; Roth D Am J Ther; 2005; 12(2):127-32. PubMed ID: 15767830 [TBL] [Abstract][Full Text] [Related]
4. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study. Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661 [TBL] [Abstract][Full Text] [Related]
5. Prevention of radiocontrast-induced nephropathy. Asif A; Epstein M Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433 [TBL] [Abstract][Full Text] [Related]
6. Recent advances in the prevention of radiocontrast-induced nephropathy. Marenzi G; Bartorelli AL Curr Opin Crit Care; 2004 Dec; 10(6):505-9. PubMed ID: 15616393 [TBL] [Abstract][Full Text] [Related]
9. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients. Madyoon H Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365 [TBL] [Abstract][Full Text] [Related]
10. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. Itoh Y; Yano T; Sendo T; Oishi R J Pharmacol Sci; 2005 Apr; 97(4):473-88. PubMed ID: 15821342 [TBL] [Abstract][Full Text] [Related]
11. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)]. Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841 [TBL] [Abstract][Full Text] [Related]
12. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785 [TBL] [Abstract][Full Text] [Related]
13. Contrast-induced nephropathy: protective role of fenoldopam. Caixeta A; Dogan O; Weisz G Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):497-505. PubMed ID: 22642656 [TBL] [Abstract][Full Text] [Related]
14. Radiocontrast-induced nephropathy: an update. Perazella MA Minerva Urol Nefrol; 2009 Sep; 61(3):215-33. PubMed ID: 19773724 [TBL] [Abstract][Full Text] [Related]
15. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy. Asif A; Epstein DL; Epstein M J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304 [TBL] [Abstract][Full Text] [Related]
16. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497 [TBL] [Abstract][Full Text] [Related]
17. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. Brophy DF Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069 [TBL] [Abstract][Full Text] [Related]
18. [Contrast-induced acute renal failure]. Giannattasio M G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365 [TBL] [Abstract][Full Text] [Related]
19. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916 [TBL] [Abstract][Full Text] [Related]